title: Images of estrogen-receptor-positive breast tumors produced by estradiol labeled with iodine I 123 at 16 alpha.
abstract: OBJECTIVE
  To examine the suitability of estradiol labeled with iodine I 123 at 16 alpha for imaging estrogen-receptor-positive breast carcinoma using imaging instrumentation that is widely available.
  
  
  METHODS
  Single-photon emission computed tomographic imaging survey of 29 women with suspected primary or expected recurrent breast carcinoma.
  
  
  METHODS
  University-based referral center.
  
  
  METHODS
  Twenty-nine women undergoing diagnosis for primary or recurrent breast carcinoma. Selection was voluntary.
  
  
  METHODS
  Qualitative imaging study designed to provide tomographic data of radioligand retention and descriptive data of imaging results.
  
  
  RESULTS
  Single-photon emission computed tomographic imaging using 123I-estradiol at 16 alpha was performed for patients with breast carcinoma. Independent readers, without knowledge of receptor status or proven disease, interpreted the films. Scintigraphic detection was most noteworthy in patients with chest wall tumors and inflammatory breast cancer. Agreement between readers was 98% for true-negative readings and 94% for true-positive readings, but only 60% for false-positive and false-negative film readings.
  
  
  CONCLUSIONS
  Our results indicated that areas shown on imaging were also found to have estrogen-receptor activity and that radioligand accumulation can occur with low frequency in some surgically explored tissue. Radioligand imaging with 16 alpha-123I-estradiol can locate estrogen-receptor-positive breast tumors, including some that may be difficult to detect using conventional diagnostic imaging.
authors.affiliation: Department of Surgery, University of Kentucky College of Medicine, Lexington.
authors.forename: D E
authors.initials: DE
authors.lastname: Kenady
authors.forename: E J
authors.initials: EJ
authors.lastname: Pavlik
authors.forename: K
authors.initials: K
authors.lastname: Nelson
authors.forename: J R
authors.initials: JR
authors.lastname: van Nagell
authors.forename: H
authors.initials: H
authors.lastname: Gallion
authors.forename: P D
authors.initials: PD
authors.lastname: DePriest
authors.forename: U Y
authors.initials: UY
authors.lastname: Ryo
authors.forename: R J
authors.initials: RJ
authors.lastname: Baranczuk
mesh_terms: D001943:Breast Neoplasms / Q000097:blood / Q000737:chemistry / Q000000981:diagnostic imaging*; D004958:Estradiol / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008111:Liver Function Tests; D008657:Metabolic Clearance Rate; D009364:Neoplasm Recurrence, Local / Q000097:blood / Q000737:chemistry / Q000000981:diagnostic imaging*; D015588:Observer Variation; D011960:Receptors, Estrogen / Q000032:analysis*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*
chemical_list: D011960:Receptors, Estrogen; D004958:Estradiol; C024871:16 alpha-iodoestradiol